Bibliometric Analysis of the Research Status and Global Trends in Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease from 2002 to 2022


Цитировать

Полный текст

Аннотация

Background:Several reviews on behavioral and psychological symptoms (BPSDs) in patients with Alzheimer’s disease (AD) have summarized the current state of this field, but global trends are unclear.

Objective:This study utilized CiteSpace to provide a global overview of the current state of research on AD and its BPSDs and to predict future research trends in the field.

Methods:Data were retrieved from the Web of Science Core Collection. Bibliometric and cooccurrence analyses were performed using CiteSpace software. In total, 787 valid publications were included in the analysis.

Results:Publications on AD and BPSD have shown an increasing trend since 2002. The United States and the University of Toronto were the countries and institutions with the highest total number of publications, respectively. Japan and China were the second and third most influential in the field. Clive Ballard was the top author in terms of the number of publications. Journal of Alzheimer's Disease had the highest number of publications on this topic. Co-occurrence analysis showed that AD, behavioral symptoms, cognitive impairment, and early markers are hot topics in this area. Non-drug management of BPSDs, pharmacological treatment, and physiotherapy will be a hot topic in this field in the future.

Conclusion:Our study visualized the relevant articles over the past 21 years to detect global hotspots and trends. Our findings may help researchers to identify research hotspots in this field and will help in the selection of appropriate research topics, while possibly leading to cross-regional cooperation.

Об авторах

Haipeng Cai

Beijing Huilongguan Hospital, Huilongguan Clinical Medical School of Peking University

Email: info@benthamscience.net

Ruonan Du

Beijing Huilongguan Hospital, Huilongguan Clinical Medical School of Peking University

Email: info@benthamscience.net

Kebing Yang

Beijing Huilongguan Hospital, Huilongguan Clinical Medical School of Peking University

Email: info@benthamscience.net

Wei Li

Beijing Huilongguan Hospital, Huilongguan Clinical Medical School of Peking University

Email: info@benthamscience.net

Zhiren Wang

Beijing Huilongguan Hospital, Huilongguan Clinical Medical School of Peking University

Автор, ответственный за переписку.
Email: info@benthamscience.net

Список литературы

  1. Gulisano, W.; Maugeri, D.; Baltrons, M.A.; Fà, M.; Amato, A.; Palmeri, A.; D’Adamio, L.; Grassi, C.; Devanand, D.P.; Honig, L.S.; Puzzo, D.; Arancio, O. Role of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the amyloid cascade. J. Alzheimers Dis., 2018, 64(s1), S611-S631. doi: 10.3233/JAD-179935 PMID: 29865055
  2. Livingston, G.; Huntley, J.; Sommerlad, A.; Ames, D.; Ballard, C.; Banerjee, S.; Brayne, C.; Burns, A.; Cohen-Mansfield, J.; Cooper, C.; Costafreda, S.G.; Dias, A.; Fox, N.; Gitlin, L.N.; Howard, R.; Kales, H.C.; Kivimäki, M.; Larson, E.B.; Ogunniyi, A.; Orgeta, V.; Ritchie, K.; Rockwood, K.; Sampson, E.L.; Samus, Q.; Schneider, L.S.; Selbæk, G.; Teri, L.; Mukadam, N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet, 2020, 396(10248), 413-446. doi: 10.1016/S0140-6736(20)30367-6 PMID: 32738937
  3. Supporting informal caregivers of people living with dementia. 2017. Available from: http://www.who.int/mental_health/neurology/dementia/dementia_the maticbrief_informal_care.pdf
  4. Querfurth, H.W.; LaFerla, F.M. Alzheimer’s Disease. N. Engl. J. Med., 2010, 362(4), 329-344. doi: 10.1056/NEJMra0909142 PMID: 20107219
  5. Scheltens, P.; Blennow, K.; Breteler, M.M.B.; de Strooper, B.; Frisoni, G.B.; Salloway, S.; Van der Flier, W.M. Alzheimer’s disease. Lancet, 2016, 388(10043), 505-517. doi: 10.1016/S0140-6736(15)01124-1 PMID: 26921134
  6. Sun, Y.; Ma, C.; Sun, H.; Wang, H.; Peng, W.; Zhou, Z.; Wang, H.; Pi, C.; Shi, Y.; He, X. Metabolism: A novel shared link between diabetes mellitus and Alzheimer’s Disease. J. Diabetes Res., 2020, 2020, 1-12. doi: 10.1155/2020/4981814 PMID: 32083135
  7. Zhao, Q.F.; Tan, L.; Wang, H.F.; Jiang, T.; Tan, M.S.; Tan, L.; Xu, W.; Li, J.Q.; Wang, J.; Lai, T.J.; Yu, J.T. The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: Systematic review and meta-analysis. J. Affect. Disord., 2016, 190, 264-271. doi: 10.1016/j.jad.2015.09.069
  8. Joling, K.J.; O’Dwyer, S.T.; Hertogh, C.M.P.M.; van Hout, H.P.J. The occurrence and persistence of thoughts of suicide, self-harm and death in family caregivers of people with dementia: A longitudinal data analysis over 2 years. Int. J. Geriatr. Psychiatry, 2018, 33(2), 263-270. doi: 10.1002/gps.4708 PMID: 28379646
  9. Dyer, S.M.; Harrison, S.L.; Laver, K.; Whitehead, C.; Crotty, M. An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. Int. Psychogeriatr., 2018, 30(3), 295-309. doi: 10.1017/S1041610217002344 PMID: 29143695
  10. Kouloutbani, K.; Venetsanou, F.; Markati, A.; Karteroliotis, K.E.; Politis, A. The effectiveness of physical exercise interventions in the management of neuropsychiatric symptoms in dementia patients: A systematic review. Int. Psychogeriatr., 2022, 34(2), 177-190. doi: 10.1017/S1041610221000193 PMID: 33818342
  11. Azermai, M. Dealing with behavioral and psychological symptoms of dementia: A general overview. Psychol. Res. Behav. Manag., 2015, 8, 181-185. doi: 10.2147/PRBM.S44775 PMID: 26170729
  12. Dimitriou, T.D.; Verykouki, E.; Papatriantafyllou, J.; Konsta, A.; Kazis, D.; Tsolaki, M. Non-Pharmacological interventions for the anxiety in patients with dementia. A cross-over randomised controlled trial. Behav. Brain Res., 2020, 390, 112617. doi: 10.1016/j.bbr.2020.112617 PMID: 32428636
  13. Pritchard, A. Statistical bibliography or bibliometrics. J. Doc., 1969, (25), 348-349.
  14. Donthu, N.; Kumar, S.; Mukherjee, D.; Pandey, N.; Lim, W.M. How to conduct a bibliometric analysis: An overview and guidelines. J. Bus. Res., 2021, 133, 285-296. doi: 10.1016/j.jbusres.2021.04.070
  15. Kokol, P.; Blažun Vošner, H.; Završnik, J. Application of bibliometrics in medicine: A historical bibliometrics analysis. Health Info. Libr. J., 2021, 38(2), 125-138. doi: 10.1111/hir.12295 PMID: 31995273
  16. Tampi, R.R.; Bhattacharya, G.; Marpuri, P. Managing Behavioral and Psychological Symptoms of Dementia (BPSD) in the era of boxed warnings. Curr. Psychiatry Rep., 2022, 24(9), 431-440. doi: 10.1007/s11920-022-01347-y PMID: 35781675
  17. Abraha, I.; Rimland, J.M.; Trotta, F.M.; Dell’Aquila, G.; Cruz-Jentoft, A.; Petrovic, M.; Gudmundsson, A.; Soiza, R.; O’Mahony, D.; Guaita, A.; Cherubini, A. Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series. BMJ Open, 2017, 7(3), e012759. doi: 10.1136/bmjopen-2016-012759 PMID: 28302633
  18. Calsolaro, V.; Femminella, G.D.; Rogani, S.; Esposito, S.; Franchi, R.; Okoye, C.; Rengo, G.; Monzani, F. Behavioral and psychological symptoms in dementia (BPSD) and the use of antipsychotics. Pharmaceuticals, 2021, 14(3), 246. doi: 10.3390/ph14030246 PMID: 33803277
  19. Kales, H.C.; Lyketsos, C.G.; Miller, E.M.; Ballard, C. Management of behavioral and psychological symptoms in people with Alzheimer’s disease: An international Delphi consensus. Int. Psychogeriatr., 2019, 31(1), 83-90. doi: 10.1017/S1041610218000534 PMID: 30068400
  20. Bessey, L.J.; Walaszek, A. Management of behavioral and psychological symptoms of dementia. Curr. Psychiatry Rep., 2019, 21(8), 66. doi: 10.1007/s11920-019-1049-5 PMID: 31264056
  21. Davies, S.J.C.; Burhan, A.M.; Kim, D.; Gerretsen, P.; Graff-Guerrero, A.; Woo, V.L.; Kumar, S.; Colman, S.; Pollock, B.G.; Mulsant, B.H.; Rajji, T.K. Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia. J. Psychopharmacol., 2018, 32(5), 509-523. doi: 10.1177/0269881117744996 PMID: 29338602
  22. Ballard, C.; Banister, C.; Khan, Z.; Cummings, J.; Demos, G.; Coate, B.; Youakim, J.M.; Owen, R.; Stankovic, S.; Tomkinson, E.B.; McDermid, J.; Ocal, D.; Testad, I.; Qayyum, M.A.; Kemos’, P.; Borejko, O.; Megalogeni, M.; Brookes, E.V.; Petrava, A.; Da Silva, M.; Nunez, K. Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer’s disease psychosis: A phase 2, randomised, placebo-controlled, double-blind study. Lancet Neurol., 2018, 17(3), 213-222. doi: 10.1016/S1474-4422(18)30039-5 PMID: 29452684
  23. Alzheimer’s disease facts and figures. Alzheimers Dement., 2016, 12(4), 459-509. doi: 10.1016/j.jalz.2016.03.001 PMID: 27570871
  24. Kales, H.C.; Gitlin, L.N.; Lyketsos, C.G. Assessment and management of behavioral and psychological symptoms of dementia. BMJ, 2015, 350, h369. doi: 10.1136/bmj.h369
  25. Porsteinsson, A.P.; Drye, L.T.; Pollock, B.G.; Devanand, D.P.; Frangakis, C.; Ismail, Z.; Marano, C.; Meinert, C.L.; Mintzer, J.E.; Munro, C.A.; Pelton, G.; Rabins, P.V.; Rosenberg, P.B.; Schneider, L.S.; Shade, D.M.; Weintraub, D.; Yesavage, J.; Lyketsos, C.G. Effect of citalopram on agitation in Alzheimer disease: The CitAD randomized clinical trial. JAMA, 2014, 311(7), 682-691. doi: 10.1001/jama.2014.93 PMID: 24549548
  26. Brodaty, H.; Ames, D.; Snowdon, J.; Woodward, M.; Kirwan, J.; Clarnette, R.; Lee, E.; Lyons, B.; Grossman, F. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J. Clin. Psychiatry, 2003, 64(2), 134-143. doi: 10.4088/JCP.v64n0205 PMID: 12633121
  27. Schneider, L.S.; Tariot, P.N.; Dagerman, K.S.; Davis, S.M.; Hsiao, J.K.; Ismail, M.S.; Lebowitz, B.D.; Lyketsos, C.G.; Ryan, J.M.; Stroup, T.S.; Sultzer, D.L.; Weintraub, D.; Lieberman, J.A. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. N. Engl. J. Med., 2006, 355(15), 1525-1538. doi: 10.1056/NEJMoa061240 PMID: 17035647
  28. Schneider, L.S.; Dagerman, K.S.; Insel, P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA, 2005, 294(15), 1934-1943. doi: 10.1001/jama.294.15.1934 PMID: 16234500
  29. Kales, H.C.; Gitlin, L.N.; Lyketsos, C.G. Management of neuropsychiatric symptoms of dementia in clinical settings: Recommendations from a multidisciplinary expert panel. J. Am. Geriatr. Soc., 2014, 62(4), 762-769. doi: 10.1111/jgs.12730 PMID: 24635665
  30. Liu, S.; Li, C.; Shi, Z.; Wang, X.; Zhou, Y.; Liu, S.; Liu, J.; Yu, T.; Ji, Y. Caregiver burden and prevalence of depression, anxiety and sleep disturbances in Alzheimer’s disease caregivers in China. J. Clin. Nurs., 2017, 26(9-10), 1291-1300. doi: 10.1111/jocn.13601 PMID: 27681477
  31. Wong, W. Economic burden of Alzheimer disease and managed care considerations. Am. J. Manag. Care, 2020, 26(8), S177-S183. PMID: 32840331
  32. FDA. Public Health Advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances. 2015. Available from: http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm053171.htm
  33. Brodaty, H.; Arasaratnam, C. Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Am. J. Psychiatry, 2012, 169(9), 946-953. doi: 10.1176/appi.ajp.2012.11101529 PMID: 22952073
  34. Leng, M.; Zhao, Y.; Xiao, H.; Li, C.; Wang, Z. Internet-based supportive interventions for family caregivers of people with dementia: Systematic review and meta-analysis. J. Med. Internet Res., 2020, 22(9), e19468. doi: 10.2196/19468 PMID: 32902388
  35. Ayalon, L.; Gum, A.M.; Feliciano, L.; Areán, P.A. Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: A systematic review. Arch. Intern. Med., 2006, 166(20), 2182-2188. doi: 10.1001/archinte.166.20.2182 PMID: 17101935
  36. Chenoweth, L.; King, M.T.; Jeon, Y.H.; Brodaty, H.; Stein-Parbury, J.; Norman, R.; Haas, M.; Luscombe, G. Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: A cluster-randomised trial. Lancet Neurol., 2009, 8(4), 317-325. doi: 10.1016/S1474-4422(09)70045-6 PMID: 19282246
  37. Ballard, C.; Corbett, A. Agitation and aggression in people with Alzheimer’s disease. Curr. Opin. Psychiatry, 2013, 26(3), 252-259. doi: 10.1097/YCO.0b013e32835f414b PMID: 23528917
  38. Yury, C.A.; Fisher, J.E. Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia. Psychother. Psychosom., 2007, 76(4), 213-218. doi: 10.1159/000101499 PMID: 17570959
  39. Jin, B.; Liu, H. Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: A systemic review and Bayesian network meta-analysis. J. Neurol., 2019, 266(10), 2363-2375. doi: 10.1007/s00415-019-09200-8 PMID: 30666436
  40. Azermai, M.; Petrovic, M.; Elseviers, M.M.; Bourgeois, J.; Van Bortel, L.M.; Vander Stichele, R.H. Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Res. Rev., 2012, 11(1), 78-86. doi: 10.1016/j.arr.2011.07.002 PMID: 21856452
  41. Van Leeuwen, E.; Petrovic, M.; van Driel, M.L.; De Sutter, A.I.; Vander Stichele, R.; Declercq, T.; Christiaens, T. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst. Rev., 2018, 3(3), CD007726. PMID: 29605970
  42. Hermida, A.P.; Tang, Y.L.; Glass, O.; Janjua, A.U.; McDonald, W.M. Efficacy and safety of ECT for Behavioral and Psychological Symptoms of Dementia (BPSD): A retrospective chart review. Am. J. Geriatr. Psychiatry, 2020, 28(2), 157-163. PMID: 31668364
  43. Tampi, R.R.; Tampi, D.J.; Young, J.; Hoq, R.; Resnick, K. The place for electroconvulsive therapy in the management of behavioral and psychological symptoms of dementia. Neurodegener. Dis. Manag., 2019, 9(6), 283-288. doi: 10.2217/nmt-2019-0018 PMID: 31701804
  44. Rao, V.; Lyketsos, C.G. The benefits and risks of ECT for patients with primary dementia who also suffer from depression. Int. J. Geriatr. Psychiatry, 2000, 15(8), 729-735. doi: 10.1002/1099-1166(200008)15:83.0.CO;2-A PMID: 10960885
  45. Hausner, L.; Damian, M.; Sartorius, A.; Frölich, L. Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia. J. Clin. Psychiatry, 2011, 72(1), 91-97. doi: 10.4088/JCP.10m05973gry PMID: 21208587
  46. Regenold, W.T.; Noorani, R.J.; Piez, D.; Patel, P. Nonconvulsive electrotherapy for treatment resistant unipolar and bipolar major depressive disorder: A proof-of-concept trial. Brain Stimul., 2015, 8(5), 855-861. doi: 10.1016/j.brs.2015.06.011 PMID: 26187603
  47. Vacas, S.M.; Stella, F.; Loureiro, J.C.; Simões do Couto, F.; Oliveira-Maia, A.J.; Forlenza, O.V. Noninvasive brain stimulation for behavioural and psychological symptoms of dementia: A systematic review and meta-analysis. Int. J. Geriatr. Psychiatry, 2019, 34(9), 1336-1345. doi: 10.1002/gps.5003 PMID: 30246461

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Bentham Science Publishers, 2024